Suchergebnisse - "ROSSELAND CAROLA"

PubPharm (20)

1

High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway

enthalten in: Scandinavian journal of gastroenterology | 2023

von Leiva, R. | Bergersen, B. | Finbråten, A. | +10

2

Composition for treatment of NAFLD

enthalten in: Europäisches Patentamt | 2021

von ROSSELAND CAROLA

3

COMPOSITION FOR TREATMENT OF NAFLD

enthalten in: Europäisches Patentamt | 2016

von ROSSELAND CAROLA

4

Composition for Treatment of Mold

enthalten in: Europäisches Patentamt | 2016

von ROSSELAND CAROLA

5

COMPOSITION FOR TREATMENT OF NAFLD

enthalten in: Europäisches Patentamt | 2016

von ROSSELAND CAROLA

6

Human health risk associated with brominated flame-retardants (BFRs)

enthalten in: Environment international | 2015

von Lyche, J. | Rosseland, C. | Berge, G. | +1

7

Human health risk associated with brominated flame-retardants (BFRs)

enthalten in: Environment international | 2015

von Lyche, J. | Rosseland, C. | Berge, G. | +1

8

FAK regulates Cdk2 in EGF-stimulated primary cultures of hepatocytes

enthalten in: Journal of cellular physiology | 2013

von Flinder, L. | Wierød, L. | Rosseland, C. | +2

9

FAK regulates Cdk2 in EGF‐stimulated primary cultures of hepatocytes

enthalten in: Journal of cellular physiology | 2013

von Flinder, L. | Wierød, L. | Rosseland, C. | +2

10

EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase

enthalten in: Journal of cellular physiology | 2011

von Flinder, L. | Timofeeva, O. | Rosseland, C. | +3